Wednesday, December 01, 2021 8:21:38 PM
This could have been worded in more ominous term towards CYDY. I will assist. Oh my, golly gee. The stock hit 10.01 19 months past. This is terrible whats a mother to do?? That and 50cents will buy a cup of coffee.
Meaning? Who cares. I dont.
Im in CYDY for the long haul. If I am correct I will be gifted a Cobra from a very astute pal. Thats a joke. Actually I asked fro a Mercedes Classic. Thats true.
Soeaking of mothers; a pal's mother bought CYDY at 7$. She asked my pal shall she hold or sell.
My pal said hold. Only a dummy would tell their mother to sell CYDY. I pity the sellers.
Dont bet the farm. A small investment can be huger than huge. 11,000$ at 1.10 buys 10,000 CYDY common. If just one indication hits in the next 5 years its a minimum of 100. 90 to 1 on the investment.
Its a million bucks. 100 PE Ratio and thats just the beginning.
Two indication? Double it. Cancer 500% Thats 5 million bucks AND an investor can honestlt state that they invested in the Miracle DRug.
Watch my Netflix Series. I'm thinking.
Meaning? Who cares. I dont.
Im in CYDY for the long haul. If I am correct I will be gifted a Cobra from a very astute pal. Thats a joke. Actually I asked fro a Mercedes Classic. Thats true.
Soeaking of mothers; a pal's mother bought CYDY at 7$. She asked my pal shall she hold or sell.
My pal said hold. Only a dummy would tell their mother to sell CYDY. I pity the sellers.
Dont bet the farm. A small investment can be huger than huge. 11,000$ at 1.10 buys 10,000 CYDY common. If just one indication hits in the next 5 years its a minimum of 100. 90 to 1 on the investment.
Its a million bucks. 100 PE Ratio and thats just the beginning.
Two indication? Double it. Cancer 500% Thats 5 million bucks AND an investor can honestlt state that they invested in the Miracle DRug.
Watch my Netflix Series. I'm thinking.
Recent CYDY News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 09:15:24 PM
- CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 01:35:02 PM
- CytoDyn Closes $17.5 Million Financing to Fund Continued Development of Leronlimab • GlobeNewswire Inc. • 03/05/2026 01:30:00 PM
- CytoDyn Presents Novel CCR5 Inhibition Mechanisms and Long-Term Survival Signals for Leronlimab in Metastatic Breast Cancer at AACR Immuno-Oncology Conference • GlobeNewswire Inc. • 02/20/2026 01:30:00 PM
- CytoDyn Announces Funding and Initiation of Expanded Access Program for Patients with Triple-negative Breast Cancer • GlobeNewswire Inc. • 01/27/2026 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/09/2026 10:15:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/09/2026 01:30:45 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/22/2025 10:15:23 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/17/2025 05:15:14 AM
- December 2025 Letter to Shareholders • GlobeNewswire Inc. • 12/16/2025 01:30:00 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 12/10/2025 10:16:32 PM
- CytoDyn to Showcase PD-L1 Upregulation and Improved Survival in Metastatic Triple Negative Breast Cancer at the San Antonio Breast Cancer Symposium • GlobeNewswire Inc. • 12/08/2025 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/02/2025 10:15:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2025 01:40:20 PM
- CytoDyn Announces Resolution of Class Action Lawsuit • GlobeNewswire Inc. • 12/01/2025 01:30:00 PM
